Phase I Study of Weekly Docetaxel and Liposomal Doxorubicin in Patients with Advanced Solid Tumors

Publisher： Karger

E-ISSN： 1423-0232|69|3|202-207

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.3, 2005-10, pp. : 202-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 216-222

Karger

Access to resources Recommend Favorite

A Dose-Escalation Study of Pegylated Liposomal Doxorubicin and Oxaliplatin in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 190-196

Karger

Access to resources Recommend Favorite

A Phase I Dose Escalation and Pharmacodynamic Study of SU5416 (Semaxanib) Combined with Weekly Cisplatin and Irinotecan in Patients with Advanced Solid Tumors

By  

Oncology Research and Treatment, Vol. 36, Iss. 11, 2013-10 ,pp. : 657-660

Karger

Access to resources Recommend Favorite

A Phase I Study of Weekly Gemcitabine and Docetaxel in Patients with Advanced Cancer: A Hoosier Oncology Group Study

By  

Oncology, Vol. 62, Iss. 4, 2002-07 ,pp. : 299-304

Karger

Access to resources Recommend Favorite

A Phase I Study of Weekly Docetaxel, 24-Hour Infusion of High-Dose Fluorouracil/Leucovorin and Cisplatin in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 239-247

Karger

Access to resources Recommend Favorite